Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Cerebellum & Ataxias|February 17, 2018
Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET studyS Hossein Fatemi, Dean F Wong, James R Brašić, et al.
Journal of Child and Adolescent Psychopharmacology|August 12, 2015
Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in AutismFedra Najjar, Thomas Owley, Matthew W Mosconi, et al.
Journal of Autism and Developmental Disorders|March 31, 2019
Whole Blood Serotonin Levels and Platelet 5-HT2A Binding in Autism Spectrum DisorderElizabeth Aaron, Alicia Montgomery, Xinguo Ren, et al.
The Lancet. Psychiatry|February 13, 2022
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trialSuma Jacob, Jeremy Veenstra-VanderWeele, Declan Murphy, et al.
JAMA Psychiatry|July 6, 2022
Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical TrialEric Hollander, Suma Jacob, Roger Jou, et al.
Journal of Neurodevelopmental Disorders|September 2, 2011
Repetitive behavior profiles: Consistency across autism spectrum disorder cohorts and divergence from Prader-Willi syndromeCindi G Flores, Gregory Valcante, Steve Guter, et al.
Biological Psychiatry|October 20, 2012
Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie volesKaren L Bales, Allison M Perkeybile, Olivia G Conley, et al.
Frontiers in Behavioral Neuroscience|February 20, 2014
Genetic imaging of the association of oxytocin receptor gene (OXTR) polymorphisms with positive maternal parentingKalina J Michalska, Jean Decety, Chunyu Liu, et al.
Research Square|July 3, 2023
The CBIT+TMS Trial: study protocol for a two-phase randomized controlled trial testing neuromodulation to augment behavior therapy for youth with chronic ticsChristine Conelea, Deanna Greene, Jennifer Alexander, et al.
Trials|July 3, 2023
The CBIT + TMS trial: study protocol for a two-phase randomized controlled trial testing neuromodulation to augment behavior therapy for youth with chronic ticsChristine Conelea, Deanna J Greene, Jennifer Alexander, et al.
Pageof 7